This also applies to all travellers transiting through countries with risk of transmission of yellow fever.

Similar documents
HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

Where is Yellow Fever found?

ZIKA VIRUS. Causes, Symptoms, Treatment and Prevention

What is Zika virus (Zika)?

Annex 2 A. Regional profile: West Africa

General Description. Significance

Yellow fever. Key facts

Carol M. Smith, M.D., M.P.H. Commissioner of Health and Mental Health Ulster County Department of Health and Mental Health May 20, 2016

Everything you ever wanted to know about Zika Virus Disease

SPECIALIZED FAMILY CARE Provider Training

Zika Virus and Control Efforts in Arizona

Zika Virus. Public Information Update/phone script. Date: March 28, 2016 Time: 11:00 a.m.

Mercer MRC A Newsletter for and about our volunteers

3/24/2017. CDC S Response to Zika ZIKA 101. Updated February 2, 2017 INTRODUCTION

Zika Virus Update. Florida Department of Health (DOH) Mark Lander. June 16, Florida Department of Health in Columbia County

THE ZIKA VIRUS. August 3, Sonia G. Pandit, MPH MBA Chief Executive Officer The Pandit Group

Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus

Zika: Frequently Asked Questions

Fact sheet. Yellow fever

CDC Responds to ZIKA Zika 101

Hepatitis B and C Basics

Disease spread primarily through the bite of an infected Aedes aegypti or Ae. albopictus mosquito.

Pre- Travel Case Studies (*with Key Pads)

Zika Virus Identifying an Emerging Threat. Florida Department of Health in Miami-Dade County Epidemiology, Disease Control, & Immunization Services

Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region. Dr Zabulon Yo, & Dr Anthony Stewart

Zika virus: Interim guidance information for LMCs (midwives), GPs and other health professionals dealing with Zika virus in pregnancy 5 February 2016

Mosquito Bourne Illnesses Information Sheet

Doral Police Department - Office of Emergency Management. Action Plan Zika Virus Prevention, Preparedness and Outreach Date: Feb.

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

Zika 101 for Occupational Safety and Health Professionals

Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive)

Emergency Preparedness for PHEIC

European Centre for Disease Prevention and Control. Zika virus disease

Zika Outbreak Discussion

MODULE 3: Transmission

Let s Talk about Diseases That Are Spread by Mosquitos

Mosquito Control Matters

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

Factsheet about Chikungunya

West Nile Virus and West Nile Encephalitis Frequently Asked Questions

Zika in Texas. How to Prevent the Spread of the Zika Virus

ESCMID Online Lecture Library. by author

( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI

AIDS in Africa. An Update. Basil Reekie

Eligibility List 2018

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

Zika Virus What Every Woman Needs to Know

Zika Virus. Frequently Asked Questions: Zika Virus and Pregnancy Version

World Health Organization Department of Communicable Disease Surveillance and Response

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

Using routine data to estimate numbers of women with female genital mutilation / cutting in European countries

UNAIDS 2013 AIDS by the numbers

SOP GEN-2016B. Revision/ Review Log Revision Date Approved by Reviewed by Revision Details/ Proposal Notes 04 October 2016

ANNEX 3: Country progress indicators

FY 2017 President s Budget Request Overview for the National Center on Birth Defects and Developmental Disabilities

Malaria. You are part of it! Healthier, fitter, safer.

THE FUTURE OF ADULT MORTALITY UNDER THE AIDS THREAT: ESTIMATING AND PROJECTING INCIDENCE; PROJECTING MORTALITY WITH HIV/AIDS *

Comparative Analyses of Adolescent Nutrition Indicators

BCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

PUBLIC HEALTH UPDATE

Mosquito Threats in LA County West Nile virus & Zika

מדינת ישראל. Tourist Visa Table

Scaling Up Nutrition Action for Africa

Addressing climate change driven health challenges in Africa

FIRST CONFIRMED CASE OF IMPORTED ZIKA VIRUS IN HOUSTON, TEXAS. Preventing Transmission

IMMUNIZATION VACCINES & EMERGENCIES

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

Fight The Bite. Michelle Cole Auburn University Outreach Director

THE CARE WE PROMISE FACTS AND FIGURES 2017

A RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA

What You Need to Know ZIKA VIRUS

Presenter Information

FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat

Create the Following Chart in your notebook. Fill in as you go through each one.

Zika virus infection Interim clinical guidance for Primary Care

World Health Day Vector-borne Disease Fact Files

Africa s slow fertility transition

Update on Meningococcal A Vaccine Development and Introduction

ZIKA VIRUS WHAT IS THE SITUATION IN SINGAPORE? 6 September 2016

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

ZIKA Virus and Mosquito Management. ACCG Rosmarie Kelly, PhD MPH 30 April 16

TRAVEL ADVISORY TO PREVENT THE IMPORTATION OF EBOLA INTO SOUTH AFRICA

! Multisectoral Information, Data, Research & Evidence - for Health, Population, Human & Social Development!

CHIKUNGUNYA: the virus that bends up

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

ZIKA The Science & Practical Prevention

Zika Virus Update. Partner Webinar 05/12/2016

Prioritizing Emergency Polio Eradication Activities

Thomas McGee, L.C. 920 Main Street, Suite 1700 Kansas City, MO (816) * Toll Free (800) WEST NILE VIRUS

ZIKA VIRUS. John J. Russell MD May 27, 2016

Zika Virus. Zika Virus. Priyanka Halde. 3 rd Year, MGM Institute of Health Sciences, Navi Mumbai December, 2016

GABON. Neglected tropical disease treatment report profile for mass treatment of NTDs

IMMUNIZATION & VACCINE PREVENTABLE DISEASES

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

Waiting in the Wings: Emergence, Impact and Control of Mosquito-Borne Viruses

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

Transcription:

JAMAICA YELLOW FEVER ENTRY REQUIREMENTS 29 MAY 2016 Vaccination against yellow fever is required to prevent the importation of yellow fever virus into Jamaica where the disease does not occur but where the mosquito vector and human hosts are present. Jamaica requires all travellers over one (1) year of age journeying from yellow fever risk countries to show proof of yellow fever vaccination by means of a valid yellow fever certificate This also applies to all travellers transiting through countries with risk of transmission of yellow fever. The certificate of yellow fever vaccination is valid for life, it should be administered at a yellow fever approved vaccination centre at least ten (10) days before travel; as the vaccine only offers adequate protection ten (10) days after administration. Failure to produce a valid yellow fever vaccination certificate (see figure 1) at a Jamaican point of entry may lead to refusal of entry, or quarantine until the traveller s certificate is produced. Quarantine will not be longer than six (6) days. Travellers who have an approved exemption certificate (see figure 2) due to medical reasons will be allowed entry. They will be provided with a Health Alert Card and will be required to report fever or other symptoms daily to the health authorities. Ad hoc monitoring visits will be carried out on these visitors by the public health authorities. The countries for which a yellow fever vaccination certificate is required for entry into Jamaica are based on the WHO advisory ANNEX 1 UPDATE AS OF 4 FEBRUARY 2016, Countries with risk of yellow fever transmission and countries requiring yellow fever vaccination http://www.who.int/ith/2015-ith-annex1.pdf. The countries are: Angola, Argentina, Benin, Bolivia, Brazil, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Colombia, Congo, Côte d Ivoire, Democratic Republic of the Congo, Ecuador, Equatorial Guinea, Ethiopia, French Guinea, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Guyana, Kenya, Liberia, Mali, Mauritania, Niger, Nigeria, Panama, Paraguay, Peru, Senegal, Sierra Leone, South Sudan, Suriname, Togo, Trinidad and Tobago, Uganda, and Venezuela.

Figure 1: Example of the International Certificate of Vaccination or Prophylaxis

Figure 2: Example of the Contraindication to Vaccination form

YELLOW FEVER FREQUENTLY ASKED QUESTIONS What is yellow fever? Yellow fever is an acute illness caused by the yellow fever virus Where is the yellow fever virus found? The yellow fever virus is found in tropical and subtropical areas in South America and Africa It is NOT found in Jamaica How is yellow fever spread? The virus is spread through the bite of infected mosquitos, such as the Aedes aegypti Mosquitoes may acquire the virus for life by biting either infected monkeys or infected humans The virus is NOT spread from person to person How soon do people get sick after being bitten by an infected mosquito? The incubation period or the time from infection to illness is usually three to six (3-6) days What are the signs and symptoms? First phase (acute): Symptoms may be mild and go unnoticed Symptomatic illness begins with fever, chills, headache, backache, general muscle pain, upset stomach, and vomiting Most patients improve and their symptoms disappear after three to four (3-4) days Second phase (toxic): Approximately, 15-25% of patients enter a second, more toxic phase within 24 hours of the initial remission As the disease progresses, weakness, jaundice, bleeding of the gums, hematemesis (vomiting of blood) and blood and protein in the urine may occur

Bleeding occurs because of problems with the clotting of blood. This is why yellow fever is referred to as a haemorrhagic fever. Illness usually lasts two (2) weeks, after which 20-50% die, the remainder of patients recovers Persons who recover from yellow fever have lifelong immunity How is yellow fever diagnosed? Diagnosis is usually based on blood tests that look for virus or antibodies that a person's immune system makes against the viral infection Who should be tested? Any person who develops jaundice within two (2) weeks of a fever, and has recently returned from travel or transited an area where there is risk of yellow fever transmission or has been in contact with a return traveller, should be tested for yellow fever What are the complications? Liver and renal failure Death How is yellow fever treated? There is no specific treatment for yellow fever If possible, patients with yellow fever should be hospitalized for treatment of their symptoms and closely observed by healthcare workers Rest, fluids, and use of pain medications and fever-reducing medications may relieve symptoms of fever and aching (acetaminophen / paracetamol) Certain medications should be avoided, such as aspirin or other nonsteroidal anti-inflammatory drugs (i.e. ibuprofen and naproxen), because these may increase the risk for bleeding Any superimposed bacterial infection should be treated with an appropriate antibiotic How can yellow fever infection be prevented? 1. Vaccination

o The yellow fever vaccine is safe and affordable, and a single dose provides life-long immunity against the disease 2. Use insect repellent. When you go outdoors, use an EPA-registered insect repellent such as those containing DEET, picaridin, IR3535, or oil of lemon eucalyptus on exposed skin. Even a short time outdoors can be long enough to get a mosquito bite. 3. Wear proper clothing to reduce mosquito bites. Wear long-sleeves, long pants and socks when outdoors. Mosquitoes may bite through thin clothing, so spraying with an EPA-registered repellent will give extra protection 4. Be aware of peak mosquito hours. The peak biting times for many mosquito species is dusk to dawn. However, Aedes aegypti, one of the mosquitoes that transmits yellow fever virus, feeds during the daytime. Take extra care to use repellent and protective clothing during daytime as well as during the evening and early morning. 5. Control of Aedus aegypti mosquitoes o Mosquito control includes identifying and eliminating mosquito breeding sites and killing adult mosquitoes FREQUENTLY ASKED QUESTIONS RELATED TO THE VACCINE Who should get the vaccine? Yellow fever vaccine is recommended for people age nine (9) months or older who are traveling to, transiting through, or living in areas at risk for yellow fever virus transmission Who should not get yellow fever vaccine? Infants younger than six (6) months of age should not get the vaccine. In addition, anyone with a severe allergy to any part of the vaccine, including eggs, chicken proteins, or gelatin should not get the vaccine

Anyone who has had a severe reaction to a previous dose of yellow fever vaccine should not be vaccinated again. If you have any of the following conditions, your healthcare provider can help you decide whether you can safely receive the vaccine: HIV/AIDS or other disease that affects the immune system Weakened immune system as a result of cancer or other medical conditions, transplant, or drug treatment (such as steroids, chemotherapy, or others that affect immune function) Thymus disorder Adults 60 years of age and older Infants 6-8 months of age Pregnant women and nursing mothers When should the vaccine be administered? It should be given at least ten (10) days prior to travel What are the side effects of yellow fever vaccination? Reactions to yellow fever vaccine are generally mild o They can include mild headaches, muscle aches, and low-grade fevers o There have been reports of extremely rare but serious events following yellow fever vaccination (life-threatening allergic reaction, disease affecting the nervous system, and disease affecting certain internal organs) How long should a woman wait to conceive after receiving a yellow fever vaccination? Yellow fever vaccination has not been known to cause any birth defects when given to pregnant women. Yellow fever vaccine has been given to many pregnant women without any apparent adverse effects on the foetus. However, since yellow fever vaccine is a live virus vaccine, it poses a theoretical risk. While a two (2) week delay between yellow fever

vaccination and conception is probably adequate, a one (1) month delay has been advocated as a more conservative approach. If a woman is inadvertently or of necessity vaccinated during pregnancy, she is unlikely to have any problems from the vaccine and her baby is very likely to be born healthy